Rolf Stahel
Rolf Stahel FRSA is a Swiss businessman who was CEO of Shire Pharmaceuticals from March 1994 to March 2003, transforming it from a private $30 million company into a member of the FTSE 100.
He attended the six-week Advanced Management Program at Harvard Business School.
He was non-executive chairman of EUSA Pharma from 2007 to 2012, prior to its acquisition by Jazz Pharmaceuticals for $650 million. He is currently Non-executive Chairman of Midatech Pharma PLC, and founder Chairman of consultancy services firm Chesyl Pharma Ltd.
He is a Fellow of the Royal Society of Arts and a member of the Royal Automobile Club.
